A mother's diet could be the key to her child's liver health? That's the intriguing premise behind groundbreaking research from the University of Oklahoma, which suggests a simple intervention during pregnancy and breastfeeding could dramatically reduce the risk of fatty liver disease in offspring. Let's dive in!
The study found that when pregnant and lactating mice were given a supplement of a naturally occurring compound, the offspring showed significantly lower rates of fatty liver disease as they aged. This compound, called indole, is produced by healthy gut bacteria when they break down tryptophan, an amino acid found in foods like turkey and nuts.
This research offers a promising avenue for preventing metabolic dysfunction-associated steatotic liver disease (MASLD), a condition that affects both adults and children, but tends to progress more rapidly in the latter and is strongly linked to diabetes. And this is the part most people miss...
"The prevalence of MASLD in children is about 30% in those with obesity and about 10% in children without obesity," explained Dr. Jed Friedman, director of the OU Health Harold Hamm Diabetes Center. He further noted that the risk is higher if a mother is obese or consumes a poor diet. The disease often goes unnoticed until liver-related symptoms appear, making early prevention crucial.
The researchers, including Dr. Karen Jonscher, hypothesized that the gut microbiome plays a vital role in the development of fatty liver disease. To test this, they fed female mice a high-fat, high-sugar (Western-style) diet during pregnancy and lactation. Some of the mice also received indole. After weaning, the offspring were raised on a normal diet before later being fed a Western-style diet to induce fatty liver disease.
"Because offspring inherit their microbiome from their mother, a poor maternal diet can shape the infant’s microbiome in harmful ways," Dr. Friedman said.
But here's where it gets controversial... Among the offspring whose mothers received indole, the results were impressive. They maintained healthier livers, gained less weight, had lower blood sugar levels, and smaller fat cells, even after being exposed to a Western-style diet later in life. Researchers also observed activation of a protective gut pathway involving the acyl hydrocarbon receptor (AHR).
Furthermore, while harmful liver fats remained unchanged, beneficial very long-chain ceramides increased. Perhaps most strikingly, when gut bacteria from these protected offspring were transferred to other mice, those mice also showed reduced liver damage – solid evidence that the microbiome itself plays a key role in protection.
While these findings are from animal studies, they open the door to new approaches for reducing the growing burden of MASLD through early prevention. Currently, there are no approved drugs for treating pediatric MASLD once it develops, except for weight loss. As Dr. Jonscher noted, "Anything we can do to improve the mother’s microbiome may help prevent the development of MASLD in the offspring. That would be far better than trying to reverse the disease once it has already progressed.”
What do you think? Could this research revolutionize how we approach liver health in children? Do you think focusing on maternal health is the key to preventing diseases in future generations? Share your thoughts in the comments below!
